{
    "symbol": "PCRX",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-04 13:23:07",
    "content": " And really what we\u2019re looking for first is that we need some algorithms from the societies in terms of how these various agents should be used in a normalized patient population and then as well as a more specific population like type 2 diabetes, especially as it relates to glycemic control with an immediate versus a long-acting corticosteroid. Your line is open. So to accommodate that, as we roll out Gen 2, we\u2019re also going to have site of care pricing where the pricing for the ASC and for the office opportunities will be lined up against the reimbursement that we\u2019re seeing for different commercial payers and workman\u2019s comp and those kinds of special opportunities where you see office practices and PMNR guys desiring to use the drug to address patient needs. Your line is open. Your line is open. Your line is open. Because of the pay discrepancy actually, when you talk to these people and again, you saw it in some of the numbers from some of the hospital chains, a number of the big time good nurses, the folks that people really covet have actually gone to be travelers, and they're going into these different situations and ZIP codes where they might be able to interact with a specific surgeon or a specific group of surgeons and procedures that are very high profit margin procedures, where you can actually afford a $40,000 a month nurse."
}